Regorafenib or rechallenge chemotherapy: which is more effective in the third-line treatment of metastatic colorectal cancer?
Cancer Chemother Pharmacol
; 83(1): 115-122, 2019 01.
Article
in En
| MEDLINE
| ID: mdl-30374523
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Phenylurea Compounds
/
Pyridines
/
Colorectal Neoplasms
/
Antineoplastic Combined Chemotherapy Protocols
/
Liver Neoplasms
/
Lung Neoplasms
/
Neoplasm Recurrence, Local
Type of study:
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Cancer Chemother Pharmacol
Year:
2019
Document type:
Article
Affiliation country:
Turkey
Country of publication:
Germany